The new approach establishes an opportunity to harness the success of immunotherapies that revolutionized the treatment of childhood leukemias for childhood brain cancers.
Most people exposed to the parasites behind babesiosis don't get sick, but for others, the infection can be deadly.
Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...
WATERBURY — City native Charles Monagan, knows what it is like to hear the word "incurable." He heard it 15 years ago after ...
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
The four-month-old is now waiting one hundred days to find out if the transplant was a success.
In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, ...
Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems ...
Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems ...
Kate Ellis '25 took time away from classes to prioritize the needs of a leukemia patient she had never met, making a ...
A trial for a Louisville teen illuminated the chaos of a high-profile riot in Adair County and showed how systemic errors ...
Researchers at the University of Houston, in collaboration with Baylor College of Medicine, are developing new devices for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback